KERYX BIOPHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$537.7M

700 transactions

Summary

KERYX BIOPHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.1MSales: $38.8M32 insiders

Date	Insider	Type	Value
2018-12-12	Carberry Christine A.(Chief Operating Officer)	D	—
2018-12-12	Carberry Christine A.(Chief Operating Officer)	D	—
2018-12-12	Cameron Kevin J	D	—
2018-12-12	Cameron Kevin J	D	—
2018-12-12	Neylan John F.(Chief Medical Officer)	D	—
2018-12-12	Neylan John F.(Chief Medical Officer)	D	—
2018-12-12	GILMAN STEVEN C	D	—
2018-12-12	GILMAN STEVEN C	D	—
2018-12-12	Heffernan Michael Thomas	D	—
2018-12-12	Heffernan Michael Thomas	D	—
2018-12-12	Regan Daniel Paul	D	—
2018-12-12	Regan Daniel Paul	D	—
2018-12-12	Morrison Jodie Pope(Interim CEO)	D	—
2018-12-12	Morrison Jodie Pope(Interim CEO)	D	—
2018-12-12	Holmes Scott A(Chief Financial Officer)	D	—
2018-12-12	Holmes Scott A(Chief Financial Officer)	D	—
2018-12-12	Enyedy Mark J	D	—
2018-12-12	Enyedy Mark J	D	—
2018-12-12	ROGERS MICHAEL W	D	—
2018-12-12	ROGERS MICHAEL W	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

KERYX BIOPHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope